title: Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment.
authors.affiliation: Department of Pediatrics, National Jewish Health, Denver, CO.
authors.forename: Ruby F
authors.initials: RF
authors.lastname: Fernandez-Boyanapalli
authors.affiliation: Laboratory of Clinical Infectious Diseases, NIAID, NIH, Bethesda, MD.
authors.forename: Emilia Liana
authors.initials: EL
authors.lastname: Falcone
authors.affiliation: Laboratory of Clinical Infectious Diseases, NIAID, NIH, Bethesda, MD.
authors.forename: Christa S
authors.initials: CS
authors.lastname: Zerbe
authors.affiliation: Laboratory of Clinical Infectious Diseases, NIAID, NIH, Bethesda, MD.
authors.forename: Beatriz E
authors.initials: BE
authors.lastname: Marciano
authors.affiliation: Department of Pediatrics, National Jewish Health, Denver, CO.
authors.forename: S Courtney
authors.initials: SC
authors.lastname: Frasch
authors.affiliation: Department of Pediatrics, National Jewish Health, Denver, CO.
authors.forename: Peter M
authors.initials: PM
authors.lastname: Henson
authors.affiliation: Laboratory of Clinical Infectious Diseases, NIAID, NIH, Bethesda, MD.
authors.forename: Steven M
authors.initials: SM
authors.lastname: Holland
authors.affiliation: Department of Pediatrics, National Jewish Health, Denver, CO.
authors.forename: Donna L
authors.initials: DL
authors.lastname: Bratton
mesh_terms: D000293:Adolescent; D000328:Adult; D000818:Animals; D002478:Cells, Cultured; D002648:Child; D004195:Disease Models, Animal; D005260:Female; D006105:Granulomatous Disease, Chronic / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D018836:Inflammation Mediators / Q000378:metabolism; D008264:Macrophages / Q000187:drug effects* / Q000276:immunology; D008297:Male; D051379:Mice; D008875:Middle Aged; D008928:Mitochondria / Q000378:metabolism*; D047495:PPAR gamma / Q000378:metabolism; D010587:Phagocytosis / Q000187:drug effects; D000077205:Pioglitazone; D017382:Reactive Oxygen Species / Q000378:metabolism; D045162:Thiazolidinediones / Q000008:administration & dosage*; D055815:Young Adult
chemical_list: D007004:Hypoglycemic Agents; D018836:Inflammation Mediators; D047495:PPAR gamma; D017382:Reactive Oxygen Species; D045162:Thiazolidinediones; D000077205:Pioglitazone